Early sepsis detection trial at University of Maryland hospitals
Part of Infections clinical trials.
This trial tests a new early warning system (SEPSys and RESCUE scores) to spot sepsis before it gets serious. If you're an adult in a University of Maryland hospital without sepsis, the system may help your doctors act faster.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older at the time of admission.
- You need to be staying overnight in a participating University of Maryland Medical System hospital unit.
- Your care team must be using a special score (SEPSys or RESCUE Score) to check your risk.
- You cannot have been diagnosed with sepsis already during this hospital stay.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how a measurement from a bedside heart ultrasound changes while treating people with sepsis or septic shock. It may help doctors understand how to monitor response to treatment using a quick ultrasound test.
This trial is looking for patients who have an infection and are showing early signs of getting sicker, like a high warning score. It aims to find out if doctors can identify those at risk of sepsis sooner so they can start treatment earlier.
This study aims to find new ways to quickly diagnose sepsis (a severe response to infection) in patients arriving at the emergency room. If successful, these new tests could help doctors start treatment faster.
This trial checks if a new tool can help doctors spot sepsis early in children. If your child is under 18, had a blood culture, and received strong antibiotics within the first day in the hospital, they may qualify.
This trial tests a new blood test called the Sepsis ImmunoScore that may help doctors quickly identify sepsis (a life-threatening infection response). The test looks at your immune system's response to see if you have sepsis, which could help you get treatment faster.
This trial is testing whether a new, highly sensitive blood test (droplet digital PCR) combined with genetic analysis can help doctors predict sepsis earlier in emergency room patients. This could lead to faster treatment and better outcomes.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.